These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22451323)

  • 1. Antioxidant enzymatic activities in Alzheimer's disease: the relationship to acetylcholinesterase inhibitors.
    Klugman A; Naughton DP; Isaac M; Shah I; Petroczi A; Tabet N
    J Alzheimers Dis; 2012; 30(3):467-74. PubMed ID: 22451323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pro-inflammatory cytokines in Alzheimer's disease in relation to the use of acetylcholinesterase inhibitors.
    Richardson C; Gard PR; Klugman A; Isaac M; Tabet N
    Int J Geriatr Psychiatry; 2013 Dec; 28(12):1312-7. PubMed ID: 23585364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential efficacy of treatment with acetylcholinesterase inhibitors in patients with mild and moderate Alzheimer's disease over a 6-month period.
    López-Pousa S; Turon-Estrada A; Garre-Olmo J; Pericot-Nierga I; Lozano-Gallego M; Vilalta-Franch M; Hernández-Ferràndiz M; Morante-Muñoz V; Isern-Vila A; Gelada-Batlle E; Majó-Llopart J
    Dement Geriatr Cogn Disord; 2005; 19(4):189-95. PubMed ID: 15677866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcholinesterase inhibitors and the risk of hip fracture in Alzheimer's disease patients: a case-control study.
    Tamimi I; Ojea T; Sanchez-Siles JM; Rojas F; Martin I; Gormaz I; Perez A; Dawid-Milner MS; Mendez L; Tamimi F
    J Bone Miner Res; 2012 Jul; 27(7):1518-27. PubMed ID: 22467182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure.
    Mintzer JE; Kershaw P
    Int J Geriatr Psychiatry; 2003 Apr; 18(4):292-7. PubMed ID: 12673604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease.
    Cooke JR; Loredo JS; Liu L; Marler M; Corey-Bloom J; Fiorentino L; Harrison T; Ancoli-Israel S
    Drugs Aging; 2006; 23(6):503-11. PubMed ID: 16872233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period.
    Bullock R; Touchon J; Bergman H; Gambina G; He Y; Rapatz G; Nagel J; Lane R
    Curr Med Res Opin; 2005 Aug; 21(8):1317-27. PubMed ID: 16083542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acetylcholinesterase inhibitor, Donepezil, regulates a Th2 bias in Alzheimer's disease patients.
    Reale M; Iarlori C; Gambi F; Feliciani C; Isabella L; Gambi D
    Neuropharmacology; 2006 Apr; 50(5):606-13. PubMed ID: 16445950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of different acetylcholinesterase inhibitors on EEG patterns in patients with Alzheimer's disease: A systematic review.
    Arjmandi-Rad S; Vestergaard Nieland JD; Goozee KG; Vaseghi S
    Neurol Sci; 2024 Feb; 45(2):417-430. PubMed ID: 37843690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Genetic Polymorphisms (SNPs) in CHRNA7 Gene on Response to Acetylcholinesterase Inhibitors (AChEI) in Patients with Alzheimer's Disease.
    Russo P; Kisialiou A; Moroni R; Prinzi G; Fini M
    Curr Drug Targets; 2017; 18(10):1179-1190. PubMed ID: 26424395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with galantamine and time to nursing home placement in Alzheimer's disease patients with and without cerebrovascular disease.
    Feldman HH; Pirttila T; Dartigues JF; Everitt B; Van Baelen B; Schwalen S; Kavanagh S
    Int J Geriatr Psychiatry; 2009 May; 24(5):479-88. PubMed ID: 18985627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug treatment of Alzheimer's disease patients leads to expression changes in peripheral blood cells.
    Calciano MA; Zhou W; Snyder PJ; Einstein R
    Alzheimers Dement; 2010 Sep; 6(5):386-93. PubMed ID: 20185375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors.
    Parnetti L; Amici S; Lanari A; Romani C; Antognelli C; Andreasen N; Minthon L; Davidsson P; Pottel H; Blennow K; Gallai V
    Neurol Sci; 2002 Sep; 23 Suppl 2():S95-6. PubMed ID: 12548360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylcholinesterase inhibitors for Alzheimer's disease: anti-inflammatories in acetylcholine clothing!
    Tabet N
    Age Ageing; 2006 Jul; 35(4):336-8. PubMed ID: 16788077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer's disease.
    Paroni G; Seripa D; Fontana A; D'Onofrio G; Gravina C; Urbano M; Cascavilla L; Pellegrini F; Greco A; Pilotto A
    Clin Interv Aging; 2014; 9():1783-91. PubMed ID: 25364236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to cholinesterase inhibitors in patients with Alzheimer's disease.
    Blais L; Kettani FZ; Perreault S; Leroux JC; Forget A; Kergoat MJ
    J Am Geriatr Soc; 2009 Feb; 57(2):366-8. PubMed ID: 19207161
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of Acetylcholinesterase Inhibitors on Cerebral Perfusion and Cognition: A Systematic Review.
    Moyaert P; Beun S; Achten E; Clement P
    J Alzheimers Dis; 2023; 93(4):1211-1221. PubMed ID: 37182871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian cholinergic rhythms: implications for cholinesterase inhibitor therapy.
    Davis B; Sadik K
    Dement Geriatr Cogn Disord; 2006; 21(2):120-9. PubMed ID: 16391473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase 1 gene polymorphisms do not influence the response to treatment in Alzheimer's disease.
    Klimkowicz-Mrowiec A; Marona M; Spisak K; Jagiella J; Wolkow P; Szczudlik A; Slowik A
    Dement Geriatr Cogn Disord; 2011; 32(1):26-31. PubMed ID: 21829028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylcholinesterase inhibitors in assisted living: patterns of use and association with retention.
    Rosenblatt A; Samus QM; Onyike CU; Baker AS; McNabney M; Mayer LS; Brandt J; Lyketsos CG
    Int J Geriatr Psychiatry; 2008 Feb; 23(2):178-84. PubMed ID: 17676652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.